InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: Investor2014 post# 142336

Sunday, 02/25/2018 9:36:01 AM

Sunday, February 25, 2018 9:36:01 AM

Post# of 462084

If I in the end have to loose money on an AD investment I’d prefer it be in a non plaque attack stock. At least then I know I haven’t been investing against all odds.



Exactly right Investor. Sometimes knowing what NOT TO DO is as important. IMO we are at an inflection point w/RS trial. If it can be proven that the CNS cellular Homeostasis restoration and regeneration (R&R) is valid then the process for CNS disease research will restart. It appears the other trials protocols have become far more complex(see delay) than previous conventional FDA methods as they progressed. Trial designers are on the dark side of precision medicine, which completely blows up the old style investment thinking. The good news is, we are #1 in the AD queue. IMO, the good news is, in the new world the people with the most $$ may not always win.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News